| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SR8278 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.4 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | -0.048 | 0.4 |
| mRNA | QW-BI-011 | CTRPv2 | pan-cancer | AAC | 0.058 | 0.4 |
| mRNA | BMS-754807 | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | -0.034 | 0.4 |
| mRNA | BRD-K49290616 | CTRPv2 | pan-cancer | AAC | -0.064 | 0.4 |
| mRNA | SNS-032 | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | ML334 diastereomer | CTRPv2 | pan-cancer | AAC | -0.039 | 0.4 |
| mRNA | SZ4TA2 | CTRPv2 | pan-cancer | AAC | -0.046 | 0.4 |
| mRNA | AZD4547 | CTRPv2 | pan-cancer | AAC | 0.031 | 0.4 |